2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Jann-Tay Wang

Session 4 – Combating Pandemics (A)
Date: 22 July (Wednesday) 14:00 – 15:30 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform


Jann-Tay Wang

Deputy Director, Department of Internal Medicine
National Taiwan University Hospital

​ 

National Taiwan University Hospital is a major teaching hospital with a total capacity of 2635 beds located in northern Taiwan. It provides both the primary and tertiary medical care.  


Speech title & Synopsis

Treatment Options for SARS-CoV-2 Infection

SARS-CoV-2 infection is an emerging infectious disease noted since Dec. 2019. Till now, it has caused a pandemic resulting in more than eleven million infections and 530 thousand deaths. Many clinicians and researchers have offered much effort to find out the effective treatment modality. Till now, several agents have been proposed as potential drugs against SARS-CoV-2 infection, which include hydroxychloroquine, remdesivir, IL-1 antagonist, and IL-6 antagonist. Brief discussion focus on current evidence for the treatment options of SARS-CoV-2 will be provided in this talk. 
​​